Filing Flows › Fennec Pharmaceuticals (FENC) › Q1 2026 › vs Q4 2025
Fennec Pharmaceuticals (FENC) Q1 2026 vs Q4 2025 (quarter over quarter)
Fennec Pharmaceuticals's revenue rose $1.3M (+10%) from $13.8M in Q4 2025 to $15.1M in Q1 2026.
Fennec Pharmaceuticals, Q1 2026: revenue $15.1M (+73% year over year), operating margin -0.8%, net earnings $201K, operating cash flow $2.4M. The chart draws each line against Q4 2025, the increases inside each band.
Every line
| Line | Q1 2026 | Q4 2025 | Change | % |
|---|---|---|---|---|
| Revenue | $15.1M | $13.8M | $1.3M | +10% |
| Other income, net | $320K | −$2.2M | $2.6M | — |
| Costs & expenses | $15.4M | $18.6M | −$3.1M | -17% |
| Operating costs | $15.2M | $16.3M | −$1.1M | -7% |
| Net earnings | $201K | −$4.8M | $5.0M | — |
| Research & development | $49K | $20K | $29K | +145% |
| Sales & marketing | $11.4M | $6.1M | $5.3M | +87% |
| General & admin | $3.2M | $8.4M | −$5.3M | -62% |
| Other operating costs | $570K | $1.8M | −$1.2M | -68% |
| Operating cash sources | $2.4M | −$6.0M | $8.3M | — |
| Share-based compensation | $990K | $2.5M | −$1.5M | -61% |
| Working capital & other | $1.2M | −$3.7M | $4.9M | — |
| Operating cash flow | $2.4M | −$6.0M | $8.3M | — |
Questions
How much did Fennec Pharmaceuticals's revenue grow quarter over quarter in Q1 2026?
Fennec Pharmaceuticals's revenue rose $1.3M (+10%) from $13.8M in Q4 2025 to $15.1M in Q1 2026.